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Summary. Changes in the numbers of serotonin- and 
substance P-immunoreactive (IR) cells occur in severa1 
animal models of diabetes. It is not known, however, 
whether these changes are a result of actual ceii loss or 
are caused by modified gene expression in ceíls showing 
co-localization of serotonin and substance P. The pattern 
of mono- and co-expression of serotonin, as well as of 
substance P, was therefore investigated in 
gastrointestinal endocrine cells from animal models of 
human type 1 and type 2 diabetes, namely non-obese 
diabetic (NOD) and obese diabetic (oblob) mice. 
Immunocytochemical staining by the avidin-biotin 
complex method was performed for computerized image 
analysis of each cell type, and by immunofluorescence 
double staining to study co-localization. Tissues from 
antrum, proximal duodenum and dista1 colon were 
investigated. Co-localization of serotonin- and substance 
P-IR was found in al1 investigated parts of the gut. In 
antrum, substance P immunoreactivity was found 
exclusively in serotonin-IR cells. In both NOD and 
oblob mice there was a reduced number of substance P- 
IR cells, but an unchanged serotonin-IR cell count, 
which thus tallies with a shut-off of substance P 
expression in antral enterochromaffin cells. In 
duodenum, both diabetes models showed a decreased 
number of serotonin-IR cells. Furthermore there was a 
decreased number of substance P-IR cells in the type 2 
model. The proportion of serotonin-IR cells showing 
substance P-immuno-reactivity was decreased in both 
diabetic models, thus indicating a shut-off of substance 
P-gene expression. However, this does not fully explain 
the changes in duodenum, but the diabetic state probably 
affects the number of mono-expressed cells as well. In 
colon, no change was found in diabetic mice regarding 
co-localization of substance P and serotonin. However, 
pre-diabetic NOD mice showed a decreased proportion 
of substance P in serotonin-IR cells, which might be 
explained by the increased number of serotonin-IR cells, 
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combined with an unchanged number of substance P-IR 
cells. In conclusion, diabetic animal models of both type 
1 and type 2 appear to have a combination of decreased 
expression of substance P in serotonin-IR cells of both 
antrum and duodenum, as well as a change in the 
number of mono-expressed cells. The pattern in colon, 
on the other hand, seems to be unaffected. 
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lntroductlon 
Motility dysfunction is  common in the gut of 
diabetic patients (Feldman and Schiller, 1983; Locke, 
1995). Both substance P and serotonin play an important 
role in the regulation of gut motility. Thus, substance P 
stimulates peristalsis and accelerates gastrointestinal 
transit, while serotonin stimulates pyloric contraction, 
small intestinal and colonic motility, as well as 
accelerating transit through the small and large intestine 
(Lidberg, 1985; Tally, 1992; Oosterbosch et al., 1993; 
Goarard et al., 1994; Dockary, 1994; von der Ohe et al., 
1994). It is conceivable that a disturbance in these 
regulatory substances occurs in the gut of diabetic 
patients. This assumption is supported by recent findings 
in animal models of type 1 and type 2 diabetes, where 
abnormalities have been reported concerning substance 
P and serotonin cells (Goes et al., 1990; Pinto et al., 
1995; El-Salhy and Sphgéus, 1998a,b; El-Salhy et al., 
1998; Spangbus and El-Salhy, 1998, 1999). Substance P 
and serotonin are both present in endocrine cells in gut 
mucosa. In humans and most other mammals, substance 
P and serotonin have been found co-localized in a sub- 
type of the enterochromaffin cell (Dockary, 1994). Co- 
localization of substance P with serotonin in 
enterochromaffin cells has not, to the best of our 
knowledge, been investigated in murine gut. 
Previous studies on serotonin and substance P in the 
gut of animal models of diabetes have been focused on 
each of these peptidelmonoamine separately. It is 
interesting, however, to ascertain whether the 
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abnormalities in cell numbers observed earlier (Goes et 
al., 1990; Pinto et al., 1995; El-Salhy and SpAngéus, 
1998a,b; El-Salhy et al., 1998; Spangéus and El-Salhy, 
1998, 1999) were a result of changes in absolute cell 
numbers, or whether they resulted from switching onloff 
of gene expression in the co-localized cells. 
The non-obese diabetic (NOD) mouse is a strain 
genetically predisposed to develop a condition similar to 
human type 1 diabetes, characterized by an abrupt onset 
of glucosuria, hypoinsulinaemia, polyphagia, polydipsia, 
polyuria, hypercholesterolaemia and ketonaemia 
(Makino et al., 1980; Kolb, 1987; Tochino, 1987). Mice 
homozygous of the autosomal-recessive ob-gene (oblob- 
mice) are characterized by hyperinsulinaemia, insulin- 
resistant hyperglycaemia, and obesity (Herberg and 
Coleman, 1977; Lord and Atkins, 1985). These 
metabolic disturbances resemble those found in human 
type 2 diabetes. 
The aims of this study were to investigate the co- 
localization of serotonin and substance P in mice, and to 
investigate whether the diabetic state influences 
peptidelmonoamine expression in the cells in which 
these substances are co-localized, or influences the 
absolute number of any of these endocrine cells. 
Material and methods 
Animals 
As an animal model for human type 1 diabetes, 22- 
24-week-old female pre-diabetic and diabetic non-obese 
diabetic (NOD/Bom) mice (BomholtgArd Breeding and 
Research Centre, Denmark) were used. These animals 
have been characterized in detail elsewhere (El-Salhy et 
al., 1998). In brief, the pre-diabetic NOD mice did not 
have glucosuria, but had reduced body weight, a 1-2 
grade insulitis, normal pancreatic insulin content and 
reduced @ut not statistically significant) pancreatic islet 
and insulin celi volume density. Diabetic NOD mice had 
glucosuria, significantly reduced body weight, a 3-4 
grade insulitis, significantly low pancreatic insulin 
content and significantly low volume density of 
pancreatic islets and insulin cells. Age-matched female 
mice of the sister strain BALBlcJ (Bomholtghd) served 
as controls. Homozygous male obese diabetic (oblob) 
mice (Umea/Bom-ob, BomholtgArd), 20 weeks old, were 
used as an animal model for human type 2 diabetes. As 
controls, non-diabetic age-matched male homozygous 
lean (+/+) mice (Bomholtghd) were used. According to 
the supplier the diabetic obese mice had a body weight 
of 101.5k2.7 g, their plasma glucose leve1 was 11.620.3 
mmoV and plasma insulin, 24.0k7.4 nglml (the values 
expressed as meankSEM). The conesponding values for 
lean controls were 42.210.6 g, 7.420.4 mmolll and 
2.310.5 ng/ml. 
Each group comprised 7 animals. To allow them to 
adapt to the vivarium conditions, they were kept there 
for one week, until sacrifice. They were housed 5 to each 
cage in a room with a 12 h lightldark cycle and were 
given standard pellet diet (Astra-Ewos AB, Sodertalje, 
Sweden) and water ad libitum. After an overnight 
starvation, the mice were killed in a C02 chamber. 
The antrum, proximal duodenum and dista1 colon 
were excised, and were fixed overnight in 4% buffered 
formaldehyde. The local committee on animal ethics at 
UmeA University approved the investigation. 
Microwave antigen retrieval 
The sections were treated as described in detail 
elsewhere (Nyhlin et al., 1997). Briefly, they were 
hydrated, and immersed in 0.01M citrate buffer, pH 6, in 
plastic Coplin jars, which were placed in a microwave 
oven for three boiling cycles of 5 min each, at maximum 
power (650 W). For each run, the sections were quickly 
transferred to a new jar with fresh retrieval solution. 
After the last run, the slides were allowed to cool to 
room temperature for 20 min, nnsed in Tris-buffer, pH 
7.6, and then imrnunostained. 
lmmunocytochemistry 
The tissue specimens were embedded in par& wax 
and sectioned at 10 pm thick. The sections were then 
immunostained with or without antigen retrieval with the 
avidin-biotiii complex (ABC) method (Dakopatts, 
Glostrup, Denmark) as described in detail earlier (El- 
Salhy et al., 1993). In brief, endogenous peroxidase was 
blocked by incubation in 0.5% H202 for 30 min. The 
slides were then heated with 1% bovine serum albumin 
for 10 minutes to occupy unspecific binding sites, 
followed by overnight incubation with the primary 
antiserum in a moisture chamber. Biotinylated swine anti- 
rabbit IgG (dilution 1:100) was applied fer 30 min, 
followed by avidin-biotin complex for 30 min. The 
sections were rinsed in 50 m1 Tris-buffer containing 10 p l  
of 30% H202 and 25 mg diaminobenzidine 
tetrahydrochloride (DAB) and counterstained lightly with 
Mayer's haemotoxylin. Al1 steps were performed at room 
temperature. The primary antisera used were rabbit anti- 
substance P (diluted 1:1000, code no. SP2-840530 B45-1, 
Eurodiagnostica, Malmo, Sweden), rabbit anti-substance 
P (diluted 1:1000, code no. B069082, BioGenex, San 
Ramon, California, USA) and anti-serotonin (diluted 
1:400, code no. R 871204 B56-1, Eurodiagnostica). 
Double immunostaining was performed by a 
procedure using indirect immunofluorescence (Lewis- 
Carl et al., 1993). Briefly, the sections were rinsed for 20 
min in a 1% solution of Triton X-100 (Kebo Lab, 
Sweden) in 0.01M phosphate-buffered saline (PBS), pH 
7.2, followed by incubation for 15 min in 5% non- 
immune swine serum. They were then incubated with 
one of the primary antisera, diluted in PBS, for 1 h at 
37 "C. After washes in PBS and incubation for another 
15 min in 5% normal swine serum, the sections were 
immersed in tetramethyl-rhodamine isothiocyanate 
(TR1TC)-conjugated swine anti-rabbit IgG (diluted 1:40, 
Dakopatts, Glostrup, Denmark) for 30 min at 37 "C. 
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This was followed by treatment with normal rabbit 
serum for 15 min and by incubation with goat anti-rabbit 
F(Ab')2 fragment (diluted 1:20, Dakopatts) for 60 min at 
37 "C. After PBS washes and a 15-min treatment with 
5% swine serum, the second primary antiserum was 
applied to the sections for 60 min at 37 "C. Following 
the PBS washes and normal swine serum treatment, 
fluorescein isothiocyanate (F1TC)-conjugated swine 
anti-rabbit IgG (diluted 1:40, Dakopatts) was applied to 
the sections for 30 min at 37 "C. The slides were then 
mounted in glycero1:PBS (1:l) and .examined in a Leitz 
Orthoplan Photomicroscope equipped with 
epifluorescence optics. 
The primary antibodies used were rabbit anti- 
substance P (diluted 1:100, code no. B069082, 
BioGenex) and rabbit anti-serotonin (diluted 1:100, code 
no. NT102, ETI, New Jersey, USA). 
Specificity controls were performed as described 
previously (Beesley, 1993; El-Salhy et al., 1993). 
Briefly, they included replacement of the primary 
antibody by non-immune rabbit serum as well as pre- 
incubation of anti-substance P with 50 p g  synthetic 
substance P, and serotonin, for 24 h at 4 OC as well as 
anti-serotonin with 50 p g  of serotonin or substance P. 
Positive controls were obtained by including sections 
from human colon in the immunostaining. The controls 
also included reversal of the order of antigen detection. 
Computerized image analysis 
Quantification of immunoreactive cells was 
performed as described earlier (El-Salhy et al., 1997). In 
brief, an Olympus microscope (type BX50) was linked 
to the Quantimet 500MC image processing and analysis 
system (Leica, Cambridge, England). The software in 
this system comprised; QWIN (version 1.02), an image 
analysis program and QUIPS (version 1.02), an 
interactive programming system. The quantification was 
performed in an automated standard analysis sequence 
as descnbed earlier (El-Salhy et al., 1997). In brief, the 
number of cells was counted using field measurements, 
and the area of epithelium by threshold settings. In each 
mouse and for substance P and serotonin, twenty fields 
were randomly chosen (from 2-4 different sections, 
separated from each other by 100 pm)  and were 
investigated in a x20 objective. At this magnification, 
each pixel of the computer image corresponded to 0.414 
pm and each field seen in the monitor represented an 
area of 0.04 mm2 of the tissue. 
In each mouse 30 substance P cells from two 
different sections (separated by at least 100 pm) were 
analysed regarding their serotonin content. In addition, 
30 serotonin cells were analysed regarding their 
substance P content. The analyses were performed with 
a Leitz Orthoplan Photomicroscope equipped with 
epifluorescence optics, using a x40 objective. 
Comparisons between two groups were performed 
using the non-parametric, Wilcoxon (Mann-Whitney) 
test. P-values below 0.05 were considered significant. 
Results 
Substance P-IR cells were clearly distinguished in 
sections immunostained after microwave antigen 
retrieval, but not in sections immunostained without 
such treatment. On the other hand, substance P-IR nerve 
fibres were observed in sections both with and without 
microwave antigen retrieval treatment. The subsequent 
description and morphometric analysis were done on 
sections immunostained following microwave antigen 
retrieval. Substance P immunoreactivity was found in 
nerve fibres and neurones of the myenteric and 
submucosal plexi as well as in endocrine cells in the 
mucosa of the antrum, duodenum, and colon of NOD 
mice, oblob-mice and control mice. The substance P-IR 
endocrine cells were numerous in duodenum and colon, 
but sparse in antrum. Serotonin-IR endocrine cells were 
numerous in the mucosa of ail investigated parts of the 
gut. Both substance P- and serotonin-IR endocrine cells 
varied in shape, from round, flask-shaped, to triangular, 
often with a basal process. 
Specificity controls, including replacement of 
primary antisera with non-immune rabbit serum, as well 
as pre-incubating the primary antisera with the 
corresponding antigen, i.e. substance P or serotonin, 
resulted in no immunostaining. Antibodies to both 
substance P and serotonin immunostained ceiis in human 
Wt. 
Cornputerized image analysis 
The numbers of both serotonin-IR and substance P- 
IR cells are presented in Figs. 1, 2. In antrum, the 
number of substance P-IR cells was decreased in pre- 
diabetic and diabetic NOD mice as well as in diabetic 
oblob mice, compared with respective control mice. No 
difference was found in the number of serotonin-IR cells 
in either NOD or oblob mice vs respective controls. 
In duodenum, whereas the number of substance P-IR 
cells decreased in diabetic oblob mice vis-A-vis their lean 
controls, no difference was found between the NOD 
mice and their controls. The number of serotonin-IR 
cells was significantly decreased in both pre-diabetic and 
diabetic NOD mice as well as in diabetic oblob mice, 
vis-a-vis their respective controls. 
In colon, no statistical difference was found between 
NOD mice or oblob mice and theh respective controls 
regarding numbers of substance P-IR cells. Whereas 
serotonin-IR cells were more numerous in pre-diabetic 
NOD mice than in controls, no difference was found in 
diabetic NOD mice. In oblob mice, the number of 
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serotonin was decreased vs control mice. 
Co-localization of substance P and serotonin was 
found in al1 investigated parts of the gut. In antrum, al1 
of the few existing substance P cells seemed to coexist 
with the serotonin, which is why no further 
quantification was made. In duodenum and colon there 
were pure serotonin cells, pure substance P cells, as well 
as co-localized serotoninJsubstance P cells (Fig. 3). 
Co-localization of serotonin and substance P is 
Anlrum l3uodmwn 
presented in Fig. 4. In diabetic NOD mice as well as in 
diabetic oblob mice, the proportion of duodenal 
serotonin-IR cells showing substance P-immuno- 
reactivity was reduced vis-a-vis their controls. No 
statistical difference was found in pre-diabetic mice vs 
controls regarding the proportion of duodenal serotonin- 
IR cells containing substance P. In colon, pre-diabetic 
NOD mice had a decreased proportion of serotonin-IR 
cells showing substance P-immunoreactivity, as 
compared with controls. No similar difference was found 
for either diabetic NOD mice or diabetic oblob mice vis- 
a-vis their respective controls. 
I OControl (lean) UDlabetlc (obiob) 
Flg. 1. Nurnbers oi serotonin- and substance P-IR endocrine cells in the Flg. 2. Nurnbers oi serotonin- and substance P-IR endocrine cells in the 
gut of NOD rnice and control mice (memin+SEM). *: P<0.05; *: P<0.01; gut of obese (oblob) rnice and control mice (meaniSEM). *: Pe0.05; 
-: P<O.OOl . *: p<0.01; -: Pc0.001. 
I Flg. 3. Mono-expressed substance P cells (red) and serotonin cells (green) as well as co-localized substance Plserotonin cells 
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